CLABF News and Press, Core One Labs Inc. From 03/12/22

VANCOUVER, British Columbia, March 12, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (the “ Company ” or “ Core One ”) is pleased to announce that its wholly-owned subsidiary Vocan ...

VANCOUVER, British Columbia, March 04, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (the “ Company ” or “ Core One ”) is pleased to announce that its wholly owned subsidiary Akome ...

Core One Labs' (OTCPK:CLABF) unit Vocan Biotechnologies successfully tested a proof-of-concept for the production of biosynthetic N-methyltryptamine (NMT), also known as monomethyl tryptamine, for use in future upscaling capabilities. The company said NMT, which belongs to a family of tr...

VANCOUVER, British Columbia, March 03, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (“ Core One ” or the “ Company ”), is pleased to announce that its wholly owned subsidiary,...

Vancouver, BC, Feb. 23, 2022 (GLOBE NEWSWIRE) -- A team of Vancouver scientists has discovered a new process to cost-effectively make psilocybin, the active ingredient in magic mushrooms, paving the way for greater and more affordable treatments for a range of addictions and mental health c...

VANCOUVER, British Columbia, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (“ Core One ” or the “ Company ”) is pleased to announce that its wholly-owned subsidiary, Vocan Biot...

Core One Labs (OTCPK:CLABF) completed the acquisition of all the outstanding share capital of psychedelics research and technology company Awakened Biosciences. Core One issued 7.03M common shares and ~1.46M share purchase warrants entitling the holders to acquire an equivalent number of...

VANCOUVER, British Columbia., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU) (the “ Company ” or “ Core One ”), a life sciences biotechnology company focused on research, de...

VANCOUVER, British Columbia, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL ), (OTC: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU ) (“ Core One ” or the “ Company ”) is pleased to announce that, further to the Company’s p...

Core One Labs (OTCPK:CLABF) said its unit Vocan Biotechnologies filed patent application for protection of its Biosynthetic Production System for Psilocybin. Core One said that with Vocan’s recombinant production system, the subsidiary successfully tested its proof-of-concept for the m...